Question 1

What is Nuvectis Pharma, Inc.'s total liabilities & equity?

Accepted Answer

Nuvectis Pharma, Inc. (NVCT) reported total liabilities & equity of $25.4M in Q1 2026.

Question 2

How has Nuvectis Pharma, Inc.'s total liabilities & equity changed year-over-year?

Accepted Answer

Nuvectis Pharma, Inc.'s total liabilities & equity decreased by 15.8% year-over-year, from $30.15M to $25.4M.

Question 3

What is the long-term trend for Nuvectis Pharma, Inc.'s total liabilities & equity?

Accepted Answer

Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s total liabilities & equity has grown at a 47.7% compound annual growth rate (CAGR), from $6.66M to $31.71M.

Question 4

What does total liabilities & equity mean?

Accepted Answer

Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Line item	March 31, 2026	December 31, 2025
TOTAL LIABILITIES	11,178	13,296
COMMITMENTS AND CONTINGENCIES, see Note 3
SHAREHOLDERS’ EQUITY, see Note 4
Common Shares, $0.00001 par value – 60,000,000 shares authorized as of March 31, 2026, and December 31, 2025, 26,525,533, and 25,676,798 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	*	*
Additional paid in capital	119,957	118,100
Accumulated deficit	(105,737)	(99,687)
TOTAL SHAREHOLDERS’ EQUITY	14,220	18,413
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$25,398	$31,709

Total Liabilities & Equity at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Returns & leverage

Where this comes from

FAQ

Ask your AI about Nuvectis Pharma, Inc.'s total liabilities & equity.

Nuvectis Pharma, Inc. NVCT Total Liabilities & Equity